GlassScriptPhysician profile
Mario Herrera
NPI 1326728874
$6,620.90
in general payments reported to CMS, 2019-2025
16 companies · $2,075 in 2025
The $2,075 reported for 2025 was more than what 93% of Psychiatric/Mental Health (Nurse Practitioner) providers received nationally (typical 2025 total: $257).
See the full distribution for Psychiatric/Mental Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $884 · 2024: $3,662 · 2025: $2,075.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,514 · Education: $107.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,514.40 |
| Education | $106.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $1,437.64 | 2023-2025 | Caplyta |
| Neurocrine Biosciences, INC. | $1,401.02 | 2023-2025 | Ingrezza |
| Teva Pharmaceuticals USA, INC. | $1,003.28 | 2023-2025 | Uzedy, Austedo Xr, Austedo Xr |
| Alkermes, INC. | $506.23 | 2023-2025 | Aristada, Lybalvi, Aristada Initio |
| E.R. Squibb & Sons, L.L.C. | $438.40 | 2024-2025 | Cobenfy |
| Axsome Therapeutics, INC. | $411.21 | 2024-2025 | Auvelity |
| Janssen Pharmaceuticals, INC | $367.42 | 2023-2025 | Invega Sustenna, Spravato |
| Otsuka America Pharmaceutical, INC. | $342.19 | 2023-2025 | Rexulti, Abilify Maintena, Abilify Asimtufii |
| Abbvie INC. | $220.68 | 2024-2025 | |
| Lundbeck LLC | $204.40 | 2024-2025 | Rexulti |
| Vanda Pharmaceuticals INC. | $129.49 | 2024 | Fanapt, Hetlioz |
| Cardiva Medical, INC. | $48.36 | 2024 | Cardiva Vascade Mvp Vvcs 6-12f |
| Teleflex LLC | $45.36 | 2025 | Chocolate, Guideliner |
| Abiomed | $22.83 | 2023 | Impella |
| Takeda Pharmaceuticals U.S.A., INC. | $21.74 | 2023 | Trintellix |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corium, LLC | $20.65 | 2024 | Azstarys |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mario Herrera listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.